- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Vidar drops plans for laser digitizer
Vidar drops plans for laser digitizerX-ray film digitizer vendor Vidar Systems has decided not to proceed with commercialization of VXR-LS, a laser film digitizer the company discussed at the 1997 meeting of the Radiological Society of North
Vidar drops plans for laser digitizer
X-ray film digitizer vendor Vidar Systems has decided not to proceed with commercialization of VXR-LS, a laser film digitizer the company discussed at the 1997 meeting of the Radiological Society of North America meeting (
PNN
1/98). Although the Herndon, VA-based company received Food and Drug Administration 510(k) clearance in April for VXR-LS, Vidar decided not to go ahead with the product because of the high maintenance required by laser digitizers and the rapidly growing performance of CCD-based digitizers.
In other Vidar news, the company has released Photoshop plug-in 2.0, which allows radiographers to operate the firm's VXR line of x-ray film digitizers from a Macintosh computer. In addition, the new release adds support for the company's Film Director option, a multi-film feeder that allows digitization of up to 10 films at a touch of a button (PNN 1/98).
- Search again
- Homepage
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
